Reshef in 2025: Profit Surged, But 2026 Will Test The Cash Quality

Getting To Know The Company

At first glance, Reshef looks like another small defense stock that happened to print an extraordinary year. That is only a partial read. The company develops, manufactures, and markets fuzes and military-electronics products, and in 2025 it moved in one step to a very different scale: revenue of NIS 523.8 million versus NIS 126.5 million in 2024, operating profit of NIS 327.3 million, and net income of NIS 308.7 million. But this jump rests on three separate layers that have to be kept apart: a very strong operating year, working capital that absorbed NIS 126.5 million, and capital moves that added another NIS 292.9 million from a share-and-options issue plus NIS 76.2 million of net collection on a controlling-shareholder debt line.

What is clearly working right now is the business itself. Gross margin widened to 68.5%, operating margin to 62.5%, and operating cash flow reached NIS 206.9 million even after a year in which receivables expanded and customer advances fell. In other words, 2025 does not read like empty accounting profit. The core activity generated far more cash than ever before.

What is still not clean is the quality of that cash. Anyone looking only at the year-end cash balance, NIS 492.9 million, could conclude that Reshef is already self-funding all of its growth, distributions, and balance-sheet flexibility. That is too early. More than 61% of the annual increase in cash came from the share-and-options issue, while receivables grew by NIS 95.1 million and customer advances fell by NIS 36.1 million. In other words, part of the 2025 jump reflects a shift away from a model in which the customer funds more of the activity in advance, toward one in which the company itself carries more of the working-capital load.

That is also why the market is likely to read 2026 first through cash quality, not through the headline profit number. At a last price of 1,381 agorot and 114.5 million shares outstanding, market cap is roughly NIS 1.58 billion. If 2025 is a new base level, this does not look like a valuation that already prices in full repeatability. If 2025 was an unusually strong year supported by equity issuance, collection from the controlling-shareholder line, and weaker customer advances, the more cautious reading is much easier to understand.

The quick economic map for Reshef looks like this:

The filing gives a clear picture of the big numbers, but almost no layer of detail on customers, geography, employees, or order structure. That is not a technical footnote. It is part of the risk. When a company shows a jump like this without full note disclosure, investors get high confidence about what happened in 2025, but much lower confidence about how much of that shift is repeatable.

Events And Triggers

The main point about 2025 is that it was not only a strong sales year. It was a structural shift year. Reshef ended the year with a different balance sheet, a different cash position, and a very different working-capital profile. Those three moves together are what turn 2026 into a proof year.

The business surge was not small, it was abrupt

Sales rose to NIS 523.8 million from NIS 126.5 million, while cost of sales rose to NIS 164.9 million from NIS 60.9 million. The result is that gross profit did not just improve, it exploded to NIS 358.9 million from NIS 65.6 million a year earlier. The same is true lower down the P&L: operating profit jumped to NIS 327.3 million from NIS 50.5 million.

The message here is straightforward. The surge is real. This is not a story of cost cutting against flat revenue, and it is not a story in which finance income replaced operating activity. Reshef simply sold far more, and at much higher profitability. Precisely because of that, the more interesting question is not whether 2025 was strong. It is whether 2025 was too exceptional to treat as a clean base.

The capital move changed the balance sheet no less than the operations

In the same year, Reshef issued shares and options, adding NIS 292.9 million to equity and financing cash flow. That is a massive move relative to the size of the company before 2025. At the same time, it paid a NIS 100 million dividend. Those two decisions together say something important about how the year should be read: management did not stop at reporting very high profit. It also built a large equity cushion and chose to return cash to shareholders.

Why does that matter? Because the same combination creates a two-sided read. On one hand, the balance sheet is far cleaner, with equity of NIS 563.7 million versus NIS 62.1 million at the end of 2024. On the other hand, it makes it harder to read year-end cash as if it came only from the business. When profit, an equity issue, and a large dividend all sit in the same year, investors have to separate the cash layers rather than settle for the headline of “almost half a billion shekels of cash.”

Working capital changed shape

The third trigger is less visible in the headline, but it is probably the most important one for 2026. Receivables rose from NIS 36.1 million to NIS 131.2 million. At the same time, customer advances fell from NIS 90.8 million to NIS 54.7 million. That is not a minor move. It means that more of the revenue base is now tied to customer credit sitting on the company’s asset side, and less to advances that fund the activity in advance.

This is not automatically a negative development. It may simply reflect higher activity, different collection terms, or execution moving faster than cash collection. But it does change earnings quality. In 2024 a larger part of the business came with built-in customer funding. In 2025 the company was already carrying more of that burden itself.

Efficiency, Profitability, And Competition

The most unusual part of Reshef’s 2025 story is not only the pace of growth. It is the depth of the margins. That is the datapoint that is hardest to assume is permanent without another round of proof. A 68.5% gross margin, a 62.5% operating margin, and a 58.9% net margin are very strong figures even relative to an already-good 2024.

That chart says two things at the same time. On one hand, it is difficult to argue that this is only a trivial one-off improvement. All three layers of profitability have been rising for three straight years. On the other hand, the speed of the 2025 move almost forces a follow-up question. Without notes, there is no way to know whether the driver was pricing, product mix, an exceptional project, favorable delivery terms, or one very profitable customer.

The cost structure reinforces the sense that this was a year of extreme operating leverage. Selling and marketing expense did rise, to NIS 20.5 million from NIS 1.5 million, but it still amounted to only 3.9% of revenue. General and administrative expense actually fell to NIS 9.2 million from NIS 12.4 million, so its share of revenue dropped to 1.8% from 9.8%. Research and development expense also remained very low, at only NIS 1.9 million, roughly 0.4% of revenue.

The natural read is that 2025 was not a year of heavy reinvestment for the next leg. It was a year of execution. The company sold much more, kept production cost and overhead far behind the growth rate, and did not open a large new expense layer in parallel. That is positive for the short term, but it also means that the 2026 test is less about whether Reshef can sell and more about whether this margin structure can hold without another similarly dramatic jump in scale.

Precisely because disclosure is thin, the competition layer remains open. There is no market breakdown here, no named customers, and no geographic split. So it is not possible to argue with confidence that the company benefited from temporary scarcity, a single anchor customer, one unusual tender, or a deep structural change in the target market. What can be said is that the numbers show an activity base with very high value per unit of sales. That may come from complex defense products, and it may also come from special 2025 conditions. Only the next run of reports can answer that properly.

Cash Flow, Debt, And Capital Structure

If there is one section that cannot be read superficially in Reshef, it is the cash section. The cash pile is real, but it is not entirely the product of internal cash generation. That is why this story needs two separate frames: normalized cash generation from the existing business, and the full cash picture after all uses and capital moves.

Normalized business cash generation looks strong

At the level of the ongoing business, operating cash flow reached NIS 206.9 million. After reported CAPEX of NIS 2.4 million, about NIS 204.5 million remains. That is a very strong picture, especially because the year also absorbed NIS 126.5 million through working-capital movement.

In other words, even after taking in the higher receivables burden and the lower customer advances, the business itself still generated a large amount of cash. That matters because it prevents the opposite extreme interpretation, as if 2025 were built only on equity financing. The business itself did work, and on a large scale.

The full cash picture is more complicated

Once operating cash flow is reduced by CAPEX, the NIS 100 million dividend, NIS 875 thousand of lease-principal repayment, and NIS 163 thousand of long-term loan repayment, only about NIS 103.5 million remains. That is still a good number, but it is very far from the year-end cash balance of NIS 492.9 million.

That gap is the core of the story. It was closed through two additional channels: NIS 292.9 million from the issue of shares and options, and NIS 76.2 million of net repayment in the controlling-shareholder debt line. So the right question is not whether Reshef has cash. It is how much of that cash reflects repeatable business cash generation rather than capital support and unusual collection from the controlling-shareholder line.

This chart makes the point clearly. The issue is not that the profit is “fake.” The issue is that not all of it reached the cash balance, mainly because of working capital. The NIS 95.1 million increase in receivables and the NIS 36.1 million drop in customer advances are the main reason for the gap between NIS 308.7 million of net income and NIS 206.9 million of operating cash flow.

That is the key datapoint because it describes a change in the funding model of the activity. In 2024 the balance sheet leaned much more on other receivables and customer advances. In 2025 Reshef leaned much more on ordinary receivables sitting as an asset. That may be a sign of healthy expansion, but it also creates a clear test: if receivables continue to expand in 2026 and customer advances do not recover, the company will have to fund more of its own growth.

The increase in cash came from three separate engines

The analytical meaning of this chart is simple: the 2025 cash pile was not built by one engine. There is a business that generated meaningful cash, but there is also a very large capital channel and a controlling-shareholder line that reversed direction and returned cash to the company after using NIS 94.9 million in 2024. That makes 2026 the year in which the equity noise has to be stripped out and the real repeatable cash engine tested on its own.

Debt itself no longer looks like the issue

Another point the market could easily miss is that balance-sheet pressure fell sharply. The current portion of the long-term bank loan fell to zero from NIS 163 thousand, and lease liabilities together came to only NIS 4.0 million. At the same time, total liabilities fell to NIS 118.5 million from NIS 128.9 million, while equity jumped to NIS 563.7 million.

That leads to an important conclusion: 2026 does not look like a debt-refinancing year or a battle-with-the-bank year. It looks like a proof year for earnings quality, collection quality, and capital-allocation decisions. That is a major change versus the end of 2024, and it is also why the market is likely to focus less on survival and more on repeatability.

Outlook And Forward View

Before moving into 2026, it helps to align four findings that a quick read can miss:

• More than 61% of the annual increase in cash came from the issue of shares and options, not from operating activity.
• Despite the jump in profit, the business already required more working-capital funding: receivables rose by NIS 95.1 million while customer advances fell by NIS 36.1 million.
• The balance sheet improved dramatically, so 2026 is not a survival year. It is a proof year for cash quality and repeatability.
• Even after absorbing the working-capital hit, the business still generated NIS 206.9 million of operating cash flow, so it is too early to dismiss 2025 as only an equity-driven event.

The forward implication is clear. 2026 is a proof year, not a passive bridge year. If Reshef can show that after the extraordinary 2025 it can still hold relatively high margins, collect receivables without opening another large working-capital hole, and avoid relying on another external capital layer, the read of 2025 will shift very quickly from “exceptional year” to “new business base.”

What has to happen for that thesis to hold? First, revenue needs to stay high enough to justify the current cost base, even if it does not repeat NIS 523.8 million. If the company comes down in volume but holds on to much of the margin, it will be easier to argue that the improvement was not only a one-off event. Second, receivables need to move much closer to cash conversion. Even if they stay elevated, they cannot keep growing faster than the cash balance. Third, customer advances need to stop eroding, or at least receivables need to be collected fast enough to offset the weaker customer funding.

The positive side is that Reshef now has enough balance-sheet cushion to let time work. With almost NIS 500 million of cash, only NIS 118.5 million of liabilities, and NIS 563.7 million of equity, the company does not look like it is heading into 2026 against a financing wall. That matters because it lets management enter the year from a position of strength rather than pressure.

But the counterpoint sits in exactly the same place. A year that combines a large equity issue, net collection from the controlling-shareholder line, and a high dividend may in hindsight look like a year in which the company reorganized the balance sheet around an especially strong result, not necessarily a year that tells investors what its natural level of profit and cash really is. If 2026 shows lower profitability and weaker cash flow, the market may end up reading 2025 as a peak event rather than the start of a new trajectory.

That is why the main short-to-medium-term trigger will be the quality of the next report, not just its headline. The market will watch three things: whether unusually strong margins are still holding, whether receivables and customer advances stop moving in a cash-negative direction, and whether the company no longer needs another capital move to preserve the cushion. If all three come through, 2025 will start to look like a base. If not, the read will turn cautious very quickly.

Risks

Profit repeatability is still unproven

A 68.5% gross margin and a 62.5% operating margin need another round of proof. Without customer detail, contract detail, or industry breakdown, there is no way to know what part of 2025 reflects a steady base and what part reflects a project, a customer, or unusually favorable commercial conditions. This is the central risk.

Working capital is the active bottleneck

Receivables rose by NIS 95.1 million and customer advances fell by NIS 36.1 million. That is the main reason operating cash flow remained below net income. If 2026 keeps moving in the same direction, a larger part of the company’s growth will be financed through the balance sheet rather than through the cash it holds.

The controlling-shareholder line has become part of the funding story

Investing cash flow included NIS 76.2 million of net repayment in the controlling-shareholder debt line in 2025, after using NIS 94.9 million in that same line in 2024. This is not a dramatic red flag, but it does mean that any reading of cash and flexibility cannot ignore movement against the controlling shareholder.

Capital allocation could look too aggressive if 2025 does not repeat

A NIS 100 million dividend in the same year as a NIS 292.9 million equity issue sharpens a simple question: how much of the cash pile is truly surplus, and how much is still needed to support a much larger revenue base. Until 2026 proves repeatability, aggressive cash distribution may look less clean than the headline implies.

Partial disclosure is itself a risk

The evidence here is enough to understand the big numbers, but not enough to unpack the customer base, credit terms, margin drivers, or order profile. For investors, that means the gap between what can be seen in the statements and what can be understood about business quality remains wider than it should be after a year like this.

Bottom Line

Reshef exits 2025 with a result that cannot be dismissed. Revenue, profitability, and the balance sheet all changed at once. What supports the thesis right now is that the activity itself generated NIS 206.9 million, the balance sheet has been almost completely stripped of debt pressure, and the company now sits on a cash cushion that was nowhere near this size a year earlier. What prevents a cleaner thesis is that year-end cash was not built only by operations, and that the shift from customer-funded activity toward a balance sheet funding more of the cycle has already started to show up in the numbers.

In the short to medium term, the market reaction will be driven less by whether 2025 was a good year and more by whether 2026 proves that the cash behind 2025 was high quality. That is the heart of the story.

Current thesis: 2025 proved that Reshef has a business capable of generating profit and cash at a much larger scale, but it still did not prove that year-end cash and profitability already represent a clean, repeatable base.

What changed versus 2024: the company moved from a relatively small balance sheet with heavier dependence on customer advances to a cash-rich, equity-rich balance sheet in which the main bottleneck is no longer debt, but the conversion of profit into shareholder-quality cash.

Counter-thesis: one can argue that the caution is overstated because even after the working-capital absorption the company generated NIS 206.9 million of operating cash flow, almost eliminated balance-sheet pressure, and built an equity and cash cushion that should let it support a larger growth phase comfortably.

What could change the market read: one more report in which margins remain relatively high, receivables stop outrunning collection, and there is no further dependence on an equity move to preserve the cash balance.

Why this matters: in a small industrial-defense company, the difference between an extraordinary earnings year and profitability that shows up again a year later is the whole story.

Over the next 2 to 4 quarters, Reshef needs to show three things: collection that starts to close the working-capital gap, margins that remain strong even after the peak year, and capital-allocation discipline that does not assume all of the cash pile is automatically distributable. What would weaken the thesis is a combination of a sharp margin decline, continued receivables expansion, or the need for another capital move to preserve the cash cushion.